This is yet another downside of unicorns ;). Though I doubt investors need much help at this point to realize how overvalued it is. Theranos will never raise at

This is yet another downside of unicorns ;). Though I doubt investors need much help at this point to realize how overvalued it is. Theranos will never raise at anything close to a $9B valuation again.